This section is still in development. Where an MS-Selfie summary is not yet available, links to the manufacturers’ patient information leaflets are provided.
Anti-CD20s (ocrelizumab, ofatumumab, ublituximab) – summary to follow
(Haematopoietic stem cell transplant)
(Avonex, Betaferon, Betaseron, Extavia, Plegridy, Rebif)
(Gilenya, Mayzent, Zeposia, Ponvory)
The link below takes you out of the MS-Selfie website to Prof G’s MS-Selfie newsletter and research archive.